Verano Holdings (VRNO) Asset Writedowns and Impairment (2021 - 2025)
Verano Holdings (VRNO) reported Asset Writedowns and Impairment of $177.4 million for Q4 2025, down 45.85% year-over-year from $327.7 million in Q4 2024, and up 3185.93% quarter-over-quarter from $5.4 million in Q3 2025.
Verano Holdings (VRNO) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Verano Holdings (VRNO) has 4 years of Asset Writedowns and Impairment data on file, last reported at $177.4 million in Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $177.4 million, down 45.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $511.0 million (up 55.99% YoY), and the FY2025 annual result was $183.3 million, down 44.07% from the prior year.
- Asset Writedowns and Impairment improved to $177.4 million in Q4 2025 per VRNO's latest filing, from $5.4 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $327.7 million in Q4 2024 and troughed at -$143000.0 in Q4 2022.
- A 4-year average of $63.9 million and a median of $290000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 794.12% in 2022 and fell as far as 68.24% in 2022.
- A 4-year view of Asset Writedowns and Impairment shows it stood at -$85000.0 in 2021, then tumbled by 68.24% to -$143000.0 in 2022, then surged by 229260.14% to $327.7 million in 2024, then plunged by 45.85% to $177.4 million in 2025.
- Business Quant data shows VRNO's Asset Writedowns and Impairment at $177.4 million in Q4 2025, $5.4 million in Q3 2025, and $428000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177.44 Mn |
| Dec 31, 2025 | 177.44 Mn |
| Sep 30, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.40 Mn |
| Jun 30, 2025 | 428,000.00 |
| Jun 30, 2025 | 428,000.00 |
| Dec 31, 2024 | 327.70 Mn |
| Dec 31, 2024 | 327.70 Mn |
| Dec 31, 2022 | -143,000.00 |
| Dec 31, 2022 | -143,000.00 |
| Sep 30, 2022 | 152,000.00 |
| Sep 30, 2022 | 152,000.00 |
| Dec 31, 2021 | -85,000.00 |
| Dec 31, 2021 | -85,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Sep 30, 2021 | 17,000.00 |